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LETTERS
not analyze changes in the outer mem-
brane proteins responsible for altera-
tion of permeability.
Continual monitoring of drug 
resistance patterns is imperative. An-
timicrobial drug susceptibility test-
ing should be conducted for clinical 
isolates, and empirical antimicrobial 
drug therapy should be changed ac-
cordingly.  AmpC  β-lactamase genes 
will eventually be transferred to ty-
phoidal salmonellae, which may pose 
a threat to public health. Spread of 
broad-spectrum  β-lactamases would 
greatly limit therapeutic options and 
leave only carbapenems and tige-
cycline as secondary antimicrobial 
drugs.
Bindiganavile N. Gokul, 
Godfred A. Menezes, 
and Belgode N. Harish
Author afﬁ  liations: Sri Devaraj Urs Medical 
College, Kolar, India (B.N. Gokul, G.A. Me-
nezes); Fortis Hospitals, Bangalore, India 
(B.N. Gokul); and Jawaharlal Institute of 
Postgraduate Medical Education and Re-
search, Pondicherry, India (G.A. Menezes, 
B.N. Harish)
DOI: 10.3201/eid1607.091643
References
  1.   Crump JA, Luby SP, Mintz ED. The glob-
al burden of typhoid fever. Bull World 
Health Organ. 2004;82:346–53.
    2.   Harish BN, Menezes GA, Sarangapani 
K, Parija SC. A case report and review of 
the literature: ciproﬂ  oxacin resistant Sal-
monella enterica serovar Typhi in India. 
J Infect Dev Ctries. 2008;2:324–7. DOI: 
10.3855/jidc.229
  3.   Al Naiemi N, Zwart B, Rijnsburger MC, 
Roosendaal R, Debets-Ossenkopp YJ, 
Mulder JA, et al. Extended-spectrum-beta-
lactamase production in a Salmonella en-
terica serotype Typhi strain from the Phil-
ippines. J Clin Microbiol. 2008;46:2794–5. 
DOI: 10.1128/JCM.00676-08
  4.   Rotimi  VO,  Jamal  W,  Pal  T,  Sovenned 
A, Albert MJ. Emergence of CTX-M-15 
type extended-spectrum β-lactamase-
producing  Salmonella spp. in Kuwait 
and the United Arab Emirates. J Med Mi-
crobiol. 2008;57:881–6. DOI: 10.1099/
jmm.0.47509-0
  5.   Singhal S, Mathur T, Khan S, Upadhay 
DJ, Chugh S, Gaind R, et al. Evaluation 
of methods for AmpC beta-lactamase in 
gram negative clinical isolates from ter-
tiary care hospitals. Indian J Med Micro-
biol. 2005;23:120–4. DOI: 10.4103/0255-
0857.16053
    6.    Mabilat C, Goussard S. PCR detection 
and identiﬁ  cation of genes for extended 
spectrum β-lactamases. In: Persiang DH, 
Smith TF, Tenover FC, White TJ, edi-
tors. Diagnostic molecular microbiology: 
principles and applications. Washington: 
American Society for Microbiology; 
1993. p. 553–9.
    7.   Pérez-Pérez FJ, Hanson ND. Detection 
of plasmid-mediated AmpC  β-lactamase 
genes in clinical isolates by using multiplex 
PCR. J Clin Microbiol. 2002;40:2153–62. 
DOI: 10.1128/JCM.40.6.2153-2162.2002
  8.   Frankel G, Newton SM, Schoolnik GK, 
Stocker BA. Unique sequences in region 
VI of the ﬂ   agellin gene of Salmonella 
typhi. Mol Microbiol. 1989;3:1379–
83. DOI: 10.1111/j.1365-2958.1989.
tb00119.x
  9.   Bidet P, Burghoffer B, Gautier V, Brahimi 
N, Mariani-Kurkdjian P, El-Ghoneimi A, 
et al. In vivo transfer of plasmid-encoded 
ACC-1  ampC from Klebsiella pneumo-
niae to Escherichia coli in an infant and 
selection of impermeability to imipenem 
in  K. pneumoniae. Antimicrob Agents 
Chemother. 2005;49:3562–5. DOI: 
10.1128/AAC.49.8.3562-3565.2005
10.   Bauernfeind A, Schneider I, Jungwirth 
R, Sahly H, Ullmann U. A novel type of 
AmpC  β-lactamase, ACC-1, produced 
by a Klebsiella pneumoniae strain caus-
ing nosocomial pneumonia. Antimicrob 
Agents Chemother. 1999;43:1924–31.
Address for correspondence: Belgode N. Harish, 
Department of Microbiology, Jawaharlal 
Institute of Postgraduate Medical Education and 
Research, Pondicherry 605006, India; email: 
drbnharish@yahoo.com
Endocarditis 
Caused by 
Actinobaculum 
schaalii, Austria
To the Editor: In May 2009, a 
52-year-old man was hospitalized 
with middle cerebral artery stroke and 
fever of unknown origin. He had a 
complicated medical history of middle 
cerebral artery stroke and mechanical 
valve replacement of the aortic valve 
2 years earlier and gastric-duodenal 
angiodysplasia. Two months before 
the most recent hospitalization, he had 
been hospitalized because of fever and 
anemia; blood cultures were positive; 
Gram stain identiﬁ  ed coryneform rods 
that did not grow in culture. Antimi-
crobial drug therapy with levoﬂ  oxacin 
(400 mg 1×/d) was initiated, and the 
patient was discharged.
At the most recent admission, 
laboratory testing showed a leukocyte 
count of 5.92 × 103 cells/μL, with 81% 
neutrophils, 7% lymphocytes, and 9% 
monocytes; thrombocyte count was 
338 × 103 cells/μL. C-reactive protein 
level was 62.6 mg/L (reference value 
<8 mg/L). Basic serum and urine 
chemical proﬁ   les and urine culture 
were unremarkable. Empiric antimi-
crobial drug therapy with piperacillin–
tazobactam (4.5 g 3×/d) was initiated 
and discontinued after 5 days because 
of clinical improvement. The next 
day, the patient’s condition deteriorat-
ed, C-reactive protein level increased 
from 15 mg/L to 32 mg/L, and blood 
was collected for culture on the day 
after piperacillin-tazobactam discon-
tinuation and the next 2 days. After 4 
days of incubation, bacterial growth 
was detected in 1 aerobic and 3 an-
aerobic samples. Gram stain showed 
positive coryneform rods. Within 48–
72 hours, the isolate yielded growth 
on blood, chocolate, and Schaedler 
agar; colonies were 1–2 mm in di-
ameter and gray. The speciﬁ  city  of 
the organism was unsatisfactory with 
the system we used (API Coryne sys-
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tem; bioMérieux, Craponne, France) 
(Table).
A 16S rRNA gene analysis was 
performed by using eubacterial uni-
versal primers. Subsequently, a 
BLAST search (www.ncbi.nlm.nih.
gov/BLAST) of the partial 16S rRNA 
gene sequence (730 bp) was performed 
by using the taxonomy browser of the 
National Center for Biotechnology 
Information (www.ncbi.nlm.nih.gov). 
Homology of 99.7% (728/730 bp) was 
detected for Actinobaculum schaalii. 
The isolate was deposited in GenBank 
under accession no. GQ355962. MICs 
were obtained for various antimicro-
bial drugs, including amoxicillin–
clavulanic acid (0.25 mg/L), pipera-
cillin–tazobactam (0.125 mg/L), and 
levoﬂ  oxacin (1 mg/L).
Infectious disease specialists 
were consulted. On physical exami-
nation, the patient exhibited Janeway 
lesions on hands and feet and a tem-
perature of 38.4°C. Transesophageal 
echocardiogram showed ﬁ  liform veg-
etation on the aortic valve, which was 
not consistent with echocardiographic 
major criteria. According to the modi-
ﬁ   ed Duke criteria (5), the patient’s 
condition fulﬁ   lled 1 major clinical 
criterion (at least 2 positive cultures 
of blood samples collected 12 hours 
apart) and 3 minor clinical criteria 
(prosthetic aortic valve, temperature 
>38°C, Janeway lesions). According-
ly, deﬁ  nite infective prosthetic valve 
endocarditis was diagnosed. Intrave-
nous antimicrobial drug therapy with 
piperacillin-tazobactam (4.5 g 3×/d) 
was initiated, followed by oral therapy 
with amoxicillin–clavulanate acid (1 g 
3×/d) for 8 weeks. Because a repeated 
transesophageal echocardiogram 10 
days after initiation of antimicrobial 
drug therapy showed no infective en-
docarditis, heart surgeons declined 
to replace the prosthetic valve. The 
patient’s condition improved, and 2 
weeks later he was discharged in good 
clinical condition.
Four species within the genus 
Actinobaculum have been described: 
A. massiliae (causing urinary tract 
infection [UTI] and superﬁ  cial  skin 
infection),  A. urinale (isolated from 
human urine), A. suis, and A. schaalii 
(1,3,4,6). A. schaalii, which is difﬁ  -
cult to identify by culture, has been re-
ported to cause UTI in elderly patients 
with underlying urologic conditions; 
a few studies have reported subse-
quent urosepsis, abscess formations, 
and osteomyelitis (1,3,6–9). Recently, 
Bank et al. (7) reported development 
of a TaqMan real-time quantitative 
PCR for A. schaalii and consecutive 
detection of the organism in 22% of 
252 routine urine samples of patients 
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Table. Comparison of isolated Actinobaculum schaalii with related human pathogens reported in the literature 
Characteristic 
Isolate that caused 
endocarditis  Reaction of (reference)* 
A. schaalii† 
A. schaalii 
(1,2) 
Actinobaculum 
massiliae (3) 
Actinobaculum 
urinale (4) 
Arcanobacterium 
pyogenes 
Actinomyces 
turicensis (1,2)
Catalase  reaction  – –  –  – – – 
ȕ-hemolysis on sheep blood 
agar 
– –/w‡  –  w  +  w 
Nitrate reduction  –  –  –  –  –  – 
Pyrazinamidase –  V  +  –  –  – 
Pyrrolidonyl arylamidase  +  +  –  –  +  – 
Alkaline phosphatase  +  –§  –  –  V  – 
ȕ-glucuroniadase –  –  –  +  +  – 
ȕ-galactosidase –  –  –  –  +  – 
Į-glucosidase +  +  +  –  +  + 
N-acetyl-ȕ-glucosaminidase –  –  –  –  V  – 
Esculin  hydrolysis  – –§  – –  –  – 
Urease activity  –  –  –  +  –  – 
Gelatin hydrolysis  –  –  –  –  +  – 
Acid from             
 Glucose  –  V  +  +  +  + 
 Ribose  +  +  +  +  +  + 
 Xylose  +  V  +  –  +  + 
 Mannitol  –  –  –  –  –  – 
 Maltose  +  +  +  +  +  V 
 Lactose  –  –  –  –  +  – 
 Sucrose  +  V  –  +  V  + 
 Glycogen  –  –  +  –  V  – 
*API Coryne system (bioMérieux, Craponne, France) profile for our isolate was compared with those described in the references (Actinobaculum schaalii 
[14 strains], A. massiliae [1 strain], A. urinale [1 strain], A. turicensis [43 strains]) and those in the manufacturer´s database for Arcanobacterium 
pyogenes. +, >90% of strains positive; –, >90% strains negative; V, variable; w, weak. 
†In API Coryne, the strain gave the profile number 4110621 (unacceptable profile because of lack of specificity). 
‡A. schaalii was described as nonhemolytic for 5 patients (1) and as showing weak ȕ-hemolysis only after 2–5 d in 9 cases (2). 
§Reported as positive for 1 of 14 strains. LETTERS
>60 years of age (8). Those ﬁ  ndings 
suggest that A. schaalii is a common 
undetected pathogen, especially in el-
derly patients with unexplained chron-
ic UTI.
We report infective endocarditis 
caused by A. schaalii. To our knowl-
edge, infective endocarditis caused by 
Actinobaculum spp. has not been re-
ported. However, several reports have 
documented endocarditis caused by 
Arcanobacterium spp. and Actinomy-
ces spp., which are phylogenetically 
related to Actinobaculum spp. (10).
Characteristics of the patient 
reported here differed from those of 
patients in previous reports. He had 
no underlying urologic condition and 
could not recall any symptoms usu-
ally associated with UTI during the 
year before hospital admission. Urine 
culture remained negative for Acti-
nobaculum spp. despite prolonged 
incubation for 5 days on chocolate 
agar in an atmosphere of 5% CO2 and 
on Schaedler agar under anaerobic 
conditions.
This report highlights the use-
fulness of the recent development of 
a speciﬁ  c real-time PCR by Bank et 
al. (7), which may prove effective not 
only for patients typically at risk for 
A. schaalii but also for patients with 
a wider spectrum of infection. More 
studies are needed to identify the real 
prevalence of disease caused by this 
difﬁ  cult-to-cultivate organism because 
it may occur in many other groups of 
patients.
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Mycobacterium 
chelonae Wound 
Infection after 
Liposuction
To the Editor: We recently inves-
tigated a case of Mycobacterium che-
lonae abdominal wound infection af-
ter liposuction performed under local 
anesthesia at an outpatient medical of-
ﬁ  ce. Our aim was to determine wheth-
er other cases of atypical mycobaterial 
infections had previously occurred af-
ter liposuction. M. chelonae is widely 
distributed in soil and water, includ-
ing tap water. Atypical mycobacterial 
infections have been associated with 
skin and soft tissue infections, includ-
ing infections after cosmetic surgeries, 
and outbreaks have been documented 
(1–4). Previously reported potential 
sources of liposuction equipment 
contamination have been inadequate 
disinfection or sterilization after rins-
ing of liposuction equipment with tap 
water, tap water used in cleaning li-
posuction cannulae, or the quaternary 
ammonium solution used to disinfect 
liposuction equipment (2,4). Increased 
numbers of procedures performed in 
freestanding medical centers (not con-
nected with hospitals) that are not rou-
tinely monitored by infection control 
committees or equivalent oversight 
bodies may contribute to atypical my-
cobacterial infection (1).
Our investigation showed that 
proper cleaning, disinfection, and 
sterilization of liposuction equipment 
and other infection control issues at 
this medical ofﬁ   ce were concerns. 
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